This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
BackgroundObesity is a global epidemic and a major risk factor for cardiovasculardiseases. This study aims to investigate the impact of weight loss after LSG on the left ventricular myocardial work (LVMW) in obese patients and explore the clinical value of the left ventricular pressure - strain loop (LV - PSL).MethodsThirty
The 2023 Almanac results derived from the Global Burden of Disease (GBD) and spanning 1990 to 2022, were recently published in the Journal of American College of Cardiology. The post Global Trends in CardiovascularDiseases: Insights from the 2023 Almanac appeared first on Cardiology Update. Original article: Mensah GA et al.
In today’s society, the prevalence of obesity has become a significant concern. have obesity, and this rate has increased by more than 10 percentage points in the past two decades. Understanding the prevalence of obesity is crucial in comprehending why events like Healthy Weight Week are essential. of adults in the U.S.
When it comes to cardiovasculardisease, two of the biggest risk factors we must consider are: ApoB concentration - A measure of the number of circulating lipid particles. Trends in the number of obese and severely obese people by region. Relationship of BMI and Risk Of Diabetes. But only moderately.
Obesity is a major global health issue and a leading cause of premature death. The prevalence of obesity has been rising faster than most other known modifiable risk factors. In a Global Burden of Disease analysis, the prevalence of obesity was found to have doubled in more than 70 countries from 1980 to 2013.
Can you please explain the concept of an obesity paradox? Salvatore Carbone, PhD: First, I’d like to point out that obesity is a major risk factor for cardiometabolic disease. 2, 3] This association is more pronounced for those with class I obesity, which is a body mass index (BMI) between 30-35 kg/m2.
The greatest risk for a shortened life expectancy and early onset of diseases arises when you move from pre-diabetes to diabetes. A diagnosis of diabetes pulls forward the time you are likely to develop cardiovasculardisease by a whopping ten years 6. All of these patients had a BMI >27. How To Reverse Diabetes.
Body mass index (BMI) ‘(weight (kg)/height (m) 2 ) was calculated and patients with BMI ≥30 kg/m 2 were categorised as obese. The mean BMI was 27.48±4.93 kg/m 2 and 23.2% (255) were categorised as obese. to 0.96, p=0.033) for postprocedure in-hospital morbidity. to 7.15, p=0.007).
Association between epicardial adipose tissue (EAT) and cardiac dysfunction in severe obesity. BMI, body mass index; GLS, global longitudinal strain; LASct, left atrial contractile strain. Abstract Aim Epicardial adipose tissue (EAT) plays a role in obesity-related heart failure with preserved ejection fraction. p = 0.045).
kg/m2), normal weight (18.524 kg/m2), overweight (2428 kg/m2), and obese (>28 kg/m2). kg/m2), normal weight (18.524 kg/m2), overweight (2428 kg/m2), and obese (>28 kg/m2). as BMI increased by category, and it prevailed more frequently among women and older people regardless of their BMI status.
Meanwhile, Metabolically healthy obesity (MHO) trends are understudied in association with stroke. Patients were categorized into a metabolically healthy obese MHO+ve cohort, BMI> 30, and MHO-ve cohort, BMI<30. Stroke, Volume 55, Issue Suppl_1 , Page ATP262-ATP262, February 1, 2024.
Background:GLP-1 receptor agonists (GLP1RA) agonists have been shown to reduce cardiovascular events in patients with type 2 diabetes (T2D) and atherosclerotic cardiovasculardisease (ASCVD). Compared to the control group, the GLP1RA cohort had a higher baseline risk profile (BMI: 35.1 [SD Hispanic, 9.6% Asian, and 4.6%
The study, “Comprehensive Cardiovascular Risk Factor Control with a Mobile Health Cardiovascular Risk Self-Management Program,” highlights the potential use of digital health technology in the comprehensive control of risk factors for cardiovasculardisease (CVD), the leading cause of death and disability in the United States.
Variable LN morphology on screening mammograms in women with obesity due to ectopic fat deposition. Logistic regression then examined associations between lymph node size, 10-year CVD risk, MACE, T2DM, HTN, low density lipoprotein (LDL), age, and BMI.
Share JUPITER In 2008 a landmark paper was published showing that in people without cardiovasculardisease and relatively normal LDL-cholesterol (<3.4 mmol/l or 130 mg/dl), the use of rosuvastatin 20mg significantly reduced the likelihood of major cardiovascular events 1. What To Do?
Source: [link] Shivering for metabolic health The first study recruited 15 men and women with a BMI between 27 and 35. Given the strong link between high triglycerides and cardiovasculardisease, this finding holds significant clinical promise. Central neural circuits involved in shivering thermogenesis. 1 Sellers, A.J.,
But resistance training hasn’t been the focus when it comes to improving cardiovascular health and preventing/reversing cardiovasculardiseases (CVDs) — that honor goes to aerobic exercise training, for which the cardiovascular benefits are well-established and vast. The answer is yes.
But resistance training hasn’t been the focus when it comes to improving cardiovascular health and preventing/reversing cardiovasculardiseases (CVDs) — that honor goes to aerobic exercise training, for which the cardiovascular benefits are well-established and vast. The answer is yes.
Food and Drug Administration ( FDA ) has approved an additional indication for Wegovy ( semaglutide ) to reduce the risk of major cardiovascular events such as death, heart attack, or stroke in adults with known heart disease and with either obesity or overweight along with a reduced calorie diet and increased physical activity.
We've known for a long time that smoking tobacco is linked to heart disease, and this study is evidence that smoking cannabis appears to also be a risk factor for cardiovasculardisease, which is the leading cause of death in the United States,” Jeffers said.
Case Study: A Common Clinical Scenario This case study highlights the complex relationship between metabolic disease and liver health. This patient’s case presents a common and challenging scenario in primary care and endocrinology, where T2D, obesity, and metabolic dysfunction intersect with liver disease.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content